Suppr超能文献

对乙酰氨基酚过量患者静脉注射N-乙酰半胱氨酸的处置与动力学

The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.

作者信息

Prescott L F, Donovan J W, Jarvie D R, Proudfoot A T

机构信息

Regional Poisoning Treatment Centre, Edinburgh, Scotland.

出版信息

Eur J Clin Pharmacol. 1989;37(5):501-6. doi: 10.1007/BF00558131.

Abstract

Seventeen patients received standard treatment with intravenous N-acetylcysteine for 18 episodes of severe poisoning with paracetamol (acetaminophen). The dose of N-acetylcysteine was 150 mg/kg given in 15 min followed by 50 mg/kg in 4 h and 100 mg/kg over the next 16 h. Liver damage was absent or mild on 13 occasions (ALT greater than 500 mu/l) and severe on 5 (ALT less than 1000 mu/l). Total plasma N-acetylcysteine was estimated by HPLC. The mean maximum plasma concentration after the initial loading dose was 554 mg/l. Concentrations then fell rapidly and after 12 h a mean steady-state level of about 35 mg/l was maintained. When the infusion was discontinued N-acetylcysteine disappeared with a half-life of 5.7 h. The mean steady-state volume of distribution, AUC, mean residence time and total clearance were 536 ml/kg, 1748 mg.h.l-1, 2.91 h and 3.18 ml.min-1.kg-1. These values are generally consistent with those previously reported with much smaller doses and the disposition of N-acetylcysteine does not appear to be dose-dependent. The elimination of N-acetylcysteine was not impaired in the patients with severe liver damage, and the pharmacokinetic variables and plasma concentrations were similar in patients with and without hepatotoxicity. The dosage schedule for intravenous N-acetylcysteine should probably be modified since adverse reactions invariably occur early when plasma concentrations are at their highest, and liver damage was prevented just as effectively at the lowest as at the highest Cmax. High initial concentrations of N-acetylcysteine can be avoided with simple alternative regimens based on the kinetic data of this study.

摘要

17名患者因18次对乙酰氨基酚严重中毒接受了静脉注射N-乙酰半胱氨酸的标准治疗。N-乙酰半胱氨酸的剂量为150mg/kg,15分钟内静脉输注完毕,随后4小时内给予50mg/kg,接下来16小时内给予100mg/kg。13例患者肝脏损害不存在或轻微(谷丙转氨酶大于500μ/l),5例严重(谷丙转氨酶小于1000μ/l)。采用高效液相色谱法测定血浆总N-乙酰半胱氨酸。初始负荷剂量后平均最大血浆浓度为554mg/l。随后浓度迅速下降,12小时后维持在约35mg/l的平均稳态水平。停止输注后,N-乙酰半胱氨酸以5.7小时的半衰期消失。平均稳态分布容积、药时曲线下面积、平均驻留时间和总清除率分别为536ml/kg、1748mg·h·l-1、2.91小时和3.18ml·min-1·kg-1。这些值与先前报道的小得多的剂量下的值总体一致,且N-乙酰半胱氨酸的处置似乎不依赖于剂量。严重肝损害患者中N-乙酰半胱氨酸的消除未受影响,有肝毒性和无肝毒性患者的药代动力学变量和血浆浓度相似。静脉注射N-乙酰半胱氨酸的给药方案可能应予以调整,因为不良反应总是在血浆浓度最高时早期出现,且在最低Cmax和最高Cmax时预防肝损害的效果一样好。根据本研究的动力学数据,采用简单的替代方案可避免N-乙酰半胱氨酸的高初始浓度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验